X0306 4/A 2014-03-03 2014-03-05 1 0001177648 ENANTA PHARMACEUTICALS INC ENTA 0001183073 TVM V LIFE SCIENCE VENTURES GMBH & CO KG C/O TVM CAPITAL CROUP OTTOSTRASSE 4 MUNICH 2M 80333 GERMANY 0 0 1 0 0001342938 TVM V Life Science Ventures Management GmbH & Co. KG C/O TVM CAPITAL GROUP OTTOSTRASSE 4 MUNICH 2M 80333 GERMANY 0 0 1 0 0001106929 TVM IV GMBH & CO KG C/O TVM CAPITAL GROUP OTTOSTRASSE 4 MUNICH 2M 80333 GERMANY 0 0 1 0 0001342940 TVM IV Management GmbH & Co. KG C/O TVM CAPITAL GROUP OTTOSTRASSE 4 MUNICH 2M 80333 GERMANY 0 0 1 0 0001133935 TVM MEDICAL VENTURES GMBH & CO KG C/O TVM CAPITAL GROUP OTTOSTRASSE 4 MUNICH 2M 80333 GERMANY 0 0 1 0 0001342939 TVM Capital GmbH C/O TVM CAPITAL GROUP OTTOSTRASSE 4 MUNICH 2M 80333 GERMANY 0 0 1 0 0001398598 Birner Hubert C/O TVM CAPITAL GROUP OTTOSTRASSE 4 MUNICH 2M 80333 GERMANY 0 0 1 0 0001398596 Fischer Stefan C/O TVM CAPITAL GROUP OTTOSTRASSE 4 MUNICH 2M 80333 GERMANY 0 0 1 0 0001397372 Goll Alexandra C/O TVM CAPITAL GROUP OTTOSTRASSE 4 MUNICH 2M 80333 GERMANY 0 0 1 0 0001133921 SCHUHSLER HELMUT C/O TVM CAPITAL GROUP OTTOSTRASSE 4 MUNICH 2M 80333 GERMANY 0 0 1 0 Common Stock 2014-03-03 4 S 0 1402 38.8337 D 343505 D Common Stock 2014-03-03 4 S 0 1874 38.8337 D 459064 D Common Stock 2014-03-03 4 S 0 5795 38.8337 D 1419812 D Common Stock 2014-03-04 4 S 0 66506 38.8155 D 276999 D Common Stock 2014-03-04 4 S 0 88877 38.8155 D 370187 D Common Stock 2014-03-04 4 S 0 274880 38.8155 D 1144932 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.80 to $39.03, inclusive. Each Reporting Person undertakes to provide to Enanta Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The shares are directly held by TVM Medical Ventures GmbH & Co. KG ("Medical Ventures"), the general partner of which is TVM Capital GmbH ("TVM Capital"), for which Alexandra Goll ("Goll") and Helmut Schuhsler ("Schuhsler"), each members of the investment committee of TVM Capital, share voting and investment authority over the shares held by Medical Ventures with the other members of the investment committee. Each of TVM Capital, Goll and Schuhsler disclaims beneficial ownership of these shares except to the extent of their pecuniary interest therein, if any. The shares are directly held by TVM IV GmbH & Co. KG ("TVM IV"), the managing limited partner of which is TVM IV Management GmbH & Co. KG ("TVM IV Management"), for which Goll and Schuhsler, each members of the investment committee of TVM IV Management, share voting and investment authority over the shares held by TVM IV with the other members of the investment committee. Each of TVM IV Management, Goll and Schuhsler disclaims beneficial ownership of these shares except to the extent of their pecuniary interest therein, if any. The shares are directly held by TVM V Life Science Ventures GmbH & Co. KG ("TVM V"), the managing limited partner of which is TVM V Life Science Ventures Management GmbH & Co. KG ("TVM V Management"), for which Hubert Birner ("Birner"), Stefan Fischer ("Fischer"), Goll and Schuhsler, each members of the investment committee of TVM V Management, share voting and investment authority over the shares held by TVM V. Each of TVM V Management, Birner, Fischer, Goll and Schuhsler disclaims beneficial ownership of these shares except to the extent of their pecuniary interest therein, if any. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.80 to $39.62, inclusive. Each Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The totals in Column 5 are being amended in order to correct a calculation error with respect to the number of shares held by each Reporting Person after the transactions reported herein and on the Form 4 filed with the SEC by each Reporting Person on 2/27/2014 (the "Previous Filing"). The number of shares disposed of by each Reporting Person and reported herein and in the Previous Filing were accurately reported and have not been amended. /s/ Josef Moosholzer, Managing Limited Partner of TVM V Life Science Ventures Management GmbH & Co. KG, managing limited partner of TVM V Life Science Ventures GmbH & Co. KG 2014-03-07 /s/ Josef Moosholzer, Managing Limited Partner of TVM V Life Science Ventures Management GmbH & Co. KG 2014-03-07 /s/ Josef Moosholzer, Managing Limited Partner of TVM IV Mangement GmbH & Co. KG, managing limited partner of TVM IV GmbH & Co. KG 2014-03-07 /s/ Josef Moosholzer, Managing Limited Partner of TVM IV Mangement GmbH & Co. KG 2014-03-07 /s/ Josef Moosholzer, Managing Limited Partner of TVM Capital GmbH, general partner of TVM Medical Ventures GmbH & Co. KG 2014-03-07 /s/ Josef Moosholzer, Managing Limited Partner of TVM Capital GmbH 2014-03-07 /s/ Rolf Starck by power of Attorney for Hubert Birner 2014-03-07 /s/ Rolf Starck by power of Attorney for Stefan Fischer 2014-03-07 /s/ Rolf Starck by power of Attorney for Alexandra Goll 2014-03-07 /s/ Rolf Starck by power of Attorney for Helmut Schuhsler 2014-03-07